ZW
Zwfis
Community Contributor
Followers1Total number of followers
Comments0Total number of comments
Member Since2025Date joined

No bio added yet

No link added
PLX logo
Protalix BioTherapeutics
ZW
Zwfis
Community Contributor

Protalix BioTherapeutics aims for $3.20 by year-end amidst strong revenue growth

As of right now the stock as a current yield of about 2.42%, with a return on equity of about 6.79%. So a bit off of my goals of at least 5% and 10%.
View narrative
US$4.31
FV
61.3% undervalued intrinsic discount
14.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
New narrative